PPLPHARMA.NSPPLPHARMA.NSNSE
Loading
EV to Sales HistoryNormalizing
Percentile Rank50
3Y CAGR-2.2%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-2.2%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20253.78+47.8%
20242.56+33.6%
20231.91-52.6%
20224.04+5.1%
20213.84-